Suchergebnisse - "Breccia, Massimo"

PubPharm (150)

1

Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation

enthalten in: European journal of haematology | 2024

von Laganà, A. | Passucci, M. | Pepe, S. | +7

2

Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy

enthalten in: Cancer | 2024

von Palandri, F. | Palumbo, G. | Benevolo, G. | +34

3

The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib

enthalten in: Annals of hematology | 2024

von Mulas, O. | Abruzzese, E. | Luciano, L. | +26

4

Interferon in chronic myeloid leukaemia : Is it useful for treatment-free remission?

enthalten in: British journal of haematology | 2023

von Breccia, M. | Saglio, G.

5

Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials

enthalten in: Annals of hematology | 2023

von Luciano, L. | Latagliata, R. | Gugliotta, G. | +18

6

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib

enthalten in: Blood cancer journal | 2023

von Palandri, F. | Elli, E. | Auteri, G. | +41

7

Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors

enthalten in: Current opinion in oncology | 2022

von Breccia, M. | Assanto, G. | Laganà, A. | +2

8

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib : 10-year followup of the GIMEMA CML 0307 study

enthalten in: Haematologica | 2022

von Gugliotta, G. | Castagnetti, F. | Breccia, M. | +23

9

RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib : validation in a real-life cohort

enthalten in: Blood advances | 2022

von Scalzulli, E. | Ielo, C. | Luise, C. | +6

10

Management of Myelofibrosis during Treatment with Ruxolitinib : A Real-World Perspective in Case of Resistance and/or Intolerance

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Breccia, M. | Palandri, F. | Guglielmelli, P. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]